Want to join the conversation?
$EQIX 2Q15 Call: Regarding regulatory status of the deal, Equinix has received approval of our request to work through EU commission to secure clearance for the acquisition and efficient process that will use a single regulatory authority to evaluate this transaction.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.